Dear Sir, Please find attached copy of News Paper Publication in which Audited Financial Results for the Quarter and Year ended 31st March 2026 are published, one in English and one in Vernacular language.
Dear Sir/Ma'am, Please find Financial Results for the quarter and year ended 31.03.2026
Dear Sir, Please find Outcome of the Board Meeting held on 30 May, 2026 of Omkar Pharmachem Limited
Dear Sir/Ma'am, Please find Annual Secretarial Compliance report for the year ended 31.03.2026 of Omkar Pharmachem Limited.
Omkar Pharmachem Ltd. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial results for quarter and year ended on 31st March 2026.
Dear Sir/Ma'am, Please find Intimation under Reg 30 of SEBI (LODR) Regulations, 2015 for change in name of Managing Director of the company.
Dear Sir, Please find Newspaper Publication regarding Special Window for Transfer & Demat of Physical Shares.
Dear Sir/Ma'am, Please find Certificate under Ref. 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.03.2026.
Dear Sir, Pursuant to SEBI (LODR), 2015 as amended and in compliance with the terms of Code of Conduct of the company, please note that the Trading Window for dealing in the securitites of the company will remain closed fir the designated persons and their immediate relatives from Wednesday, 01.04.2026 till the completion of 48 hours after the daye of declaration of Audited Financial results for the quarter and Year ended on 31.03.2026.
Dear Sir/Ma'am, Please find Newspaper Publication regarding special window for transfer and dematerialization of physical shares.
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.11 | 0.09 |
| YOY Revenue Growth % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -22.22% | -33.33% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.11 | 0.09 |
| Total Expenses + | 0.09 | 0.04 | 0.07 | 0.09 | 0.09 | 0.05 | 0.05 | 0.09 | 0.10 | 0.07 | 0.07 | 0.07 |
| Cost of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Benefit Expense | 0.03 | 0.04 | 0.06 | 0.04 | 0.04 | 0.03 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Other Expenses | 0.06 | 0.01 | 0.01 | 0.02 | 0.05 | 0.01 | 0.01 | 0.02 | 0.05 | 0.01 | 0.01 | 0.02 |
| Operating Profit | 0.05 | 0.09 | 0.07 | 0.04 | 0.05 | 0.09 | 0.08 | 0.05 | 0.04 | 0.06 | 0.04 | 0.02 |
| OPM % | 35.8% | 67% | 49.1% | 32.8% | 36.3% | 65.6% | 61.3% | 35.3% | 26.5% | 47.1% | 37.7% | 18.3% |
| Profit Before Tax + | 0.05 | 0.09 | 0.07 | 0.05 | 0.05 | 0.09 | 0.08 | 0.05 | 0.04 | 0.07 | 0.04 | 0.02 |
| Tax Expense | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.07 | 0.01 | 0.02 | 0.01 | 0.00 |
| Tax % | 0% | 0% | 0% | 133.3% | 0% | 0% | 0% | 145.2% | 25.7% | 25.4% | 25.5% | 23.1% |
| Profit After Tax | 0.05 | 0.09 | 0.07 | -0.02 | 0.05 | 0.09 | 0.08 | -0.02 | 0.03 | 0.05 | 0.03 | 0.02 |
| EPS (Basic) | 0.05 | 0.09 | 0.07 | -0.02 | 0.05 | 0.09 | 0.08 | -0.02 | 0.02 | 0.05 | 0.03 | 26.87 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 0.47 | 0.54 | 0.54 | 0.54 | 0.54 | 0.27 |
| YOY Revenue Growth % | -13.89% | 0% | 0% | 0% | 100% | - |
| Other Income | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.47 | 0.54 | 0.54 | 0.54 | 0.54 | 0.27 |
| Total Expenses + | 0.31 | 0.27 | 0.29 | 0.28 | 0.33 | 0.31 |
| Employee Benefit Expense | 0.21 | 0.16 | 0.16 | 0.14 | 0.17 | 0.15 |
| Other Expenses | 0.10 | 0.09 | 0.10 | 0.09 | 0.10 | 0.10 |
| Operating Profit | 0.16 | 0.27 | 0.25 | 0.26 | 0.21 | -0.04 |
| OPM % | 33.4% | 49.6% | 46.2% | 48.4% | 39% | -13.3% |
| Profit Before Exceptional | 0.16 | 0.27 | 0.25 | 0.26 | 0.21 | -0.04 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | 0.16 | 0.27 | 0.25 | 0.26 | 0.21 | -0.04 |
| Tax Expense | 0.04 | 0.07 | 0.06 | 0.07 | 0.03 | -0.26 |
| Tax % | 25.2% | 25.6% | 25.2% | 25.2% | 13% | - |
| Profit After Tax | 0.12 | 0.20 | 0.19 | 0.20 | 0.18 | 0.22 |
| EPS (Basic) | 26.98 | 0.20 | 0.19 | 0.20 | 0.18 | 0.21 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Non-Current Assets + | 36.39 | 9.34 | 9.41 | 9.47 | 9.54 | 9.56 |
| Property, Plant & Equipment | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 |
| Capital Work in Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non-Current Investments | 36.38 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Assets + | 0.30 | 0.27 | 0.18 | 0.26 | 0.29 | 0.07 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Trade Receivables | 0.03 | 0.10 | 0.05 | 0.13 | 0.08 | 0.03 |
| Cash and Cash Equivalents | 0.22 | 0.11 | 0.07 | 0.13 | 0.21 | 0.04 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | ||||||
| Total Equity | 36.64 | 9.43 | 9.23 | 9.04 | 8.85 | 8.66 |
| Equity Share Capital | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 |
| Other Equity | 26.56 | -0.65 | -0.85 | -1.04 | -1.24 | -1.42 |
| Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Liabilities | 0.05 | 0.17 | 0.36 | 0.69 | 0.98 | 0.97 |
| Total Liabilities | 0.05 | 0.17 | 0.36 | 0.69 | 0.98 | 0.97 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activities | 0.23 | 0.24 | 0.30 | 0.28 | 0.20 | 0.00 |
| Cash from Investing Activities | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Cash from Financing Activities | -0.12 | -0.20 | -0.35 | -0.35 | -0.03 | 0.00 |
| Net Increase/Decrease in Cash | 0.11 | 0.04 | -0.06 | -0.08 | 0.17 | 0.00 |